- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.06 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x ZV1: N-{4-[5-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)pentyl]-2-fluorobenzoyl}-D-glutamic acid(Non-covalent)
- 2 x GLY: GLYCINE(Non-covalent)
GLY.2: 10 residues within 4Å:- Chain A: S.65, H.160, S.215, H.243, K.269, R.414
- Chain B: E.87, Y.95
- Ligands: ZV1.1, PLP.3
8 PLIP interactions:6 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:S.65, A:H.160, A:S.215, B:E.87, B:Y.95
- Salt bridges: A:H.243, A:K.269, A:R.414
GLY.6: 10 residues within 4Å:- Chain C: S.65, H.160, S.215, H.243, K.269, R.414
- Chain D: E.87, Y.95
- Ligands: ZV1.5, PLP.7
8 PLIP interactions:2 interactions with chain D, 6 interactions with chain C- Hydrogen bonds: D:E.87, D:Y.95, C:S.65, C:H.160, C:S.215
- Salt bridges: C:H.243, C:K.269, C:R.414
- 4 x PLP: PYRIDOXAL-5'-PHOSPHATE(Covalent)
PLP.3: 17 residues within 4Å:- Chain A: S.131, G.132, S.133, H.160, T.214, S.215, D.240, A.242, H.243, T.266, H.268, K.269
- Chain B: Y.85, Y.130, G.314, G.315
- Ligands: GLY.2
15 PLIP interactions:11 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:H.160, A:A.242, A:T.266, A:K.269
- Hydrogen bonds: A:S.131, A:G.132, A:S.133, A:S.215, A:K.269, B:Y.85, B:Y.130, B:G.314, B:G.315
- Salt bridges: A:H.268
- pi-Stacking: A:H.160
PLP.4: 15 residues within 4Å:- Chain A: Y.85, G.314, G.315
- Chain B: S.131, G.132, S.133, N.136, H.160, T.214, S.215, D.240, A.242, H.243, H.268, K.269
15 PLIP interactions:11 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:A.242, B:K.269
- Hydrogen bonds: B:G.132, B:S.133, B:S.133, B:N.136, B:T.214, B:K.269, A:Y.85, A:Y.85, A:Y.130, A:G.315
- Salt bridges: B:H.268, B:K.269
- pi-Cation interactions: B:H.160
PLP.7: 17 residues within 4Å:- Chain C: S.131, G.132, S.133, H.160, T.214, S.215, D.240, A.242, H.243, T.266, H.268, K.269
- Chain D: Y.85, Y.130, G.314, G.315
- Ligands: GLY.6
12 PLIP interactions:10 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:H.160, C:A.242, C:T.266, C:K.269
- Hydrogen bonds: C:S.131, C:G.132, C:S.133, C:S.215, D:G.314, D:G.315
- Salt bridges: C:H.268
- pi-Stacking: C:H.160
PLP.8: 15 residues within 4Å:- Chain C: Y.85, G.314, G.315
- Chain D: S.131, G.132, S.133, N.136, H.160, T.214, S.215, D.240, A.242, H.243, H.268, K.269
12 PLIP interactions:10 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:A.242, D:K.269
- Hydrogen bonds: D:G.132, D:S.133, D:S.133, D:N.136, D:T.214, C:Y.85, C:G.315
- Salt bridges: D:H.268, D:K.269
- pi-Cation interactions: D:H.160
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Katinas, J.M. et al., Structural Characterization of 5-Substituted Pyrrolo[3,2- d ]pyrimidine Antifolate Inhibitors in Complex with Human Serine Hydroxymethyl Transferase 2. Biochemistry (2024)
- Release Date
- 2024-03-20
- Peptides
- Serine hydroxymethyltransferase, mitochondrial: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.06 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x ZV1: N-{4-[5-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)pentyl]-2-fluorobenzoyl}-D-glutamic acid(Non-covalent)
- 2 x GLY: GLYCINE(Non-covalent)
- 4 x PLP: PYRIDOXAL-5'-PHOSPHATE(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Katinas, J.M. et al., Structural Characterization of 5-Substituted Pyrrolo[3,2- d ]pyrimidine Antifolate Inhibitors in Complex with Human Serine Hydroxymethyl Transferase 2. Biochemistry (2024)
- Release Date
- 2024-03-20
- Peptides
- Serine hydroxymethyltransferase, mitochondrial: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B